Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Curr Biol. 2024 Feb 26;34(4):R148-R150. doi: 10.1016/j.cub.2024.01.031.
There is mounting evidence that decision-making can be affected by treatment in Parkinson's disease. A new study shows that dopamine and deep brain stimulation, two mainstay treatments of Parkinson's, differently affect how patients make decisions weighing rewards against effort costs.
越来越多的证据表明，决策可能会受到帕金森病治疗的影响。一项新的研究表明，多巴胺和深部脑刺激，这两种帕金森病的主要治疗方法，会以不同的方式影响患者权衡奖励与努力成本的决策方式。
